Not a Member? Register Now
Email this page
Send the page "" to a friend, relative, colleague or yourself.
Separate multiple email address with a comma
We do not record any personal information entered above.
Thank you. Your email has been sent.
Install PDR’s official, FREE drug information and comparison app today! Apple | Android | Learn More
PDR Drug Communications are designed to improve the speed and efficacy of the delivery of PDR Drug Alerts, Recalls and Approvals to physicians, prescribers, and their staff.
Below are the PDR Drug Communications that have been issued by PDR Network. To view the communication details, click on the Medication name.
If you have trouble accessing Alert details, click to get the latest version of the free Adobe Acrobat Reader software for your computer.
Filter results by:
Results 1-20 of 112
May 07, 2021 — Drug Alert: Important Prescribing Information
March 19, 2021 — Drug Alert: Important Prescribing Information
March 15, 2021 — Drug Alert: Important Drug Warning
February 23, 2021 — Drug Alert: Important Drug Warning
February 16, 2021 — Drug Alert: Important Drug Warning
February 08, 2021 — Drug Alert: Important Drug Warning
October 07, 2020 — Drug Alert: Important Prescribing Information
September 18, 2020 — Drug Alert: Opioid Analgesics - FDA Required REMS for Serious Drug Risks
August 19, 2020 — Drug Alert: FDA-REQUIRED REMS SAFETY INFORMATION
August 03, 2020 — Drug Alert: FDA-REQUIRED REMS SAFETY INFORMATION
June 12, 2020 — Drug Alert: Important Prescribing Information
May 05, 2020 — Drug Alert: Important Prescribing Information
October 29, 2019 — Drug Alert: Important Prescribing Information
September 18, 2019 — Drug Alert: Opioid Analgesics - FDA Required REMS for Serious Drug Risks
September 10, 2019 — Drug Alert: Important Drug Warning
August 23, 2019 — Drug Alert: FDA-REQUIRED REMS SAFETY INFORMATION
August 01, 2019 — Drug Alert: Important Drug Warning
June 19, 2019 — Drug Alert: Important Drug Warning
May 17, 2019 — Drug Alert: Important Drug Warning
April 01, 2019 — Drug Alert: Opioid Analgesics - FDA Required REMS for Serious Drug Risks